FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2289875342> ?p ?o ?g. }

• W2289875342 endingPage "20654" @default.
• W2289875342 startingPage "20636" @default.
• W2289875342 abstract "// Michele Olivieri 1, * , Matteo Ferro 2, * , Sara Terreri 1, * , Montano Durso 1, 3 , Alessandra Romanelli 4 , Concetta Avitabile 4 , Ottavio De Cobelli 2 , Anna Messere 5 , Dario Bruzzese 6 , Ivan Vannini 7 , Luciana Marinelli 4 , Ettore Novellino 4 , Wei Zhang 8 , Mariarosaria Incoronato 9 , Gennaro Ilardi 10 , Stefania Staibano 10 , Laura Marra 11 , Renato Franco 12 , Sisto Perdonà 11 , Daniela Terracciano 13 , Bogdan Czerniak 8 , Giovanna L. Liguori 1 , Vincenza Colonna 1 , Muller Fabbri 14 , Ferdinando Febbraio 15 , George A. Calin 16, * , Amelia Cimmino 1, * 1 Institute of Genetics and Biophysics “A. Buzzati Traverso”, National Research Council (CNR), Naples, Italy 2 Division of Urology, European Institute of Oncology, Milan, Italy 3 Bio-Ker S.r.l. MultiMedica S.p.A. Naples, Italy 4 Department of Pharmacy, University of Naples “Federico II”, Naples, Italy 5 Department of Environmental, Biological and Pharmaceutical Sciences and Technologies, Second University of Naples, Naples, Italy 6 Department of Public Health, University of Naples “Federico II”, Naples, Italy 7 Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) S.r.l. IRCCS, Gene Therapy Unit, Meldola, Italy 8 Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA 9 Fondazione IRCCS SDN, Naples, Italy 10 Department of Advanced Biomedical Sciences, University of Naples “Federico II”, Naples, Italy 11 Division of Urology, IRCS National Tumor Institute, Naples, Italy 12 Department of Physical and Mental Health and Preventive Medicine, Section of Pathology, Second University of Naples, Naples, Italy 13 Department of Translational Medical Sciences, University of Naples “Federico II”, Naples, Italy 14 Department of Pediatrics and Molecular Microbiology & Immunology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Children’s Center for Cancer and Blood Diseases and The Saban Research Institute, Children’s Hospital Los Angeles, Los Angeles, CA, USA 15 Institute of Protein Biochemistry, National Research Council (CNR), Naples, Italy 16 Department of Experimental Therapeutics and The Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX, USA * These authors contributed equally to this work Correspondence to: Amelia Cimmino, e-mail: amelia.cimmino@igb.cnr.it Ferdinando Febbraio, e-mail: f.febbraio@ibp.cnr.it George A. Calin, e-mail: gcalin@mdanderson.org Keywords: microRNA, T-UCR, bladder cancer, MMP9, CASZ1 Received: January 22, 2016      Accepted: February 03, 2016      Published: March 01, 2016 ABSTRACT Ultraconserved regions (UCRs) have been shown to originate non-coding RNA transcripts (T-UCRs) that have different expression profiles and play functional roles in the pathophysiology of multiple cancers. The relevance of these functions to the pathogenesis of bladder cancer (BlCa) is speculative. To elucidate this relevance, we first used genome-wide profiling to evaluate the expression of T-UCRs in BlCa tissues. Analysis of two datasets comprising normal bladder tissues and BlCa specimens with a custom T-UCR microarray identified ultraconserved RNA (uc.) 8+ as the most upregulated T-UCR in BlCa tissues, although its expression was lower than in pericancerous bladder tissues. These results were confirmed on BlCa tissues by real-time PCR and by in situ hybridization. Although uc.8+ is located within intron 1 of CASZ1 , a zinc-finger transcription factor, the transcribed non-coding RNA encoding uc.8+ is expressed independently of CASZ1 . In vitro experiments evaluating the effects of uc.8+ silencing, showed significantly decreased capacities for cancer cell invasion, migration, and proliferation. From this, we proposed and validated a model of interaction in which uc.8+ shuttles from the nucleus to the cytoplasm of BlCa cells, interacts with microRNA (miR)-596, and cooperates in the promotion and development of BlCa. Using computational analysis, we investigated the miR-binding domain accessibility, as determined by base-pairing interactions within the uc.8+ predicted secondary structure, RNA binding affinity, and RNA species abundance in bladder tissues and showed that uc.8+ is a natural decoy for miR-596. Thus uc.8+ upregulation results in increased expression of MMP9 , increasing the invasive potential of BlCa cells. These interactions between evolutionarily conserved regions of DNA suggest that natural selection has preserved this potentially regulatory layer that uses RNA to modulate miR levels, opening up the possibility for development of useful markers for early diagnosis and prognosis as well as for development of new RNA-based cancer therapies." @default.
• W2289875342 created "2016-06-24" @default.
• W2289875342 creator A5001805404 @default.
• W2289875342 creator A5008036169 @default.
• W2289875342 creator A5008251529 @default.
• W2289875342 creator A5008660970 @default.
• W2289875342 creator A5012394561 @default.
• W2289875342 creator A5013938672 @default.
• W2289875342 creator A5014614796 @default.
• W2289875342 creator A5024587083 @default.
• W2289875342 creator A5027115920 @default.
• W2289875342 creator A5027952276 @default.
• W2289875342 creator A5039512751 @default.
• W2289875342 creator A5040500337 @default.
• W2289875342 creator A5040940946 @default.
• W2289875342 creator A5042227227 @default.
• W2289875342 creator A5047092395 @default.
• W2289875342 creator A5057896638 @default.
• W2289875342 creator A5067979730 @default.
• W2289875342 creator A5069116689 @default.
• W2289875342 creator A5071734801 @default.
• W2289875342 creator A5075194090 @default.
• W2289875342 creator A5075294017 @default.
• W2289875342 creator A5076699095 @default.
• W2289875342 creator A5076841133 @default.
• W2289875342 creator A5079980788 @default.
• W2289875342 creator A5087200192 @default.
• W2289875342 creator A5088962032 @default.
• W2289875342 creator A5089039975 @default.
• W2289875342 date "2016-03-01" @default.
• W2289875342 modified "2023-10-17" @default.
• W2289875342 title "Long non-coding RNA containing ultraconserved genomic region 8 promotes bladder cancer tumorigenesis" @default.
• W2289875342 cites W1977344200 @default.
• W2289875342 cites W1996760543 @default.
• W2289875342 cites W2006556963 @default.
• W2289875342 cites W2011142959 @default.
• W2289875342 cites W2014195468 @default.
• W2289875342 cites W2017426710 @default.
• W2289875342 cites W2025607075 @default.
• W2289875342 cites W2029938306 @default.
• W2289875342 cites W2042720937 @default.
• W2289875342 cites W2053855164 @default.
• W2289875342 cites W2055245741 @default.
• W2289875342 cites W2056344609 @default.
• W2289875342 cites W2059341976 @default.
• W2289875342 cites W2067410483 @default.
• W2289875342 cites W2070571588 @default.
• W2289875342 cites W2077327925 @default.
• W2289875342 cites W2083381199 @default.
• W2289875342 cites W2083543262 @default.
• W2289875342 cites W2086561953 @default.
• W2289875342 cites W2094253263 @default.
• W2289875342 cites W2095202886 @default.
• W2289875342 cites W2100990361 @default.
• W2289875342 cites W2101517749 @default.
• W2289875342 cites W2103224959 @default.
• W2289875342 cites W2111627225 @default.
• W2289875342 cites W2112192177 @default.
• W2289875342 cites W2113330771 @default.
• W2289875342 cites W2123584320 @default.
• W2289875342 cites W2125874500 @default.
• W2289875342 cites W2127648442 @default.
• W2289875342 cites W2137257434 @default.
• W2289875342 cites W2154085311 @default.
• W2289875342 cites W2154097321 @default.
• W2289875342 cites W2157795344 @default.
• W2289875342 cites W2166179294 @default.
• W2289875342 cites W2415745260 @default.
• W2289875342 cites W4294107304 @default.
• W2289875342 doi "https://doi.org/10.18632/oncotarget.7833" @default.
• W2289875342 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4991481" @default.
• W2289875342 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26943042" @default.
• W2289875342 hasPublicationYear "2016" @default.
• W2289875342 type Work @default.
• W2289875342 sameAs 2289875342 @default.
• W2289875342 citedByCount "65" @default.
• W2289875342 countsByYear W22898753422016 @default.
• W2289875342 countsByYear W22898753422017 @default.
• W2289875342 countsByYear W22898753422018 @default.
• W2289875342 countsByYear W22898753422019 @default.
• W2289875342 countsByYear W22898753422020 @default.
• W2289875342 countsByYear W22898753422021 @default.
• W2289875342 countsByYear W22898753422022 @default.
• W2289875342 countsByYear W22898753422023 @default.
• W2289875342 crossrefType "journal-article" @default.
• W2289875342 hasAuthorship W2289875342A5001805404 @default.
• W2289875342 hasAuthorship W2289875342A5008036169 @default.
• W2289875342 hasAuthorship W2289875342A5008251529 @default.
• W2289875342 hasAuthorship W2289875342A5008660970 @default.
• W2289875342 hasAuthorship W2289875342A5012394561 @default.
• W2289875342 hasAuthorship W2289875342A5013938672 @default.
• W2289875342 hasAuthorship W2289875342A5014614796 @default.
• W2289875342 hasAuthorship W2289875342A5024587083 @default.
• W2289875342 hasAuthorship W2289875342A5027115920 @default.
• W2289875342 hasAuthorship W2289875342A5027952276 @default.
• W2289875342 hasAuthorship W2289875342A5039512751 @default.
• W2289875342 hasAuthorship W2289875342A5040500337 @default.
• W2289875342 hasAuthorship W2289875342A5040940946 @default.

• next